Design Therapeutics, Inc.(DSGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DSGN Design Therapeutics, Inc.

交易中 12-23 12:57:22 EST

6.27

+0.02

+0.24%

最高6.29	最低6.04	成交量5.63万
今开6.09	昨收6.25	日振幅4.00%
总市值3.55亿	流通市值1.58亿	总股本5,662万
成交额34.70万	换手率0.22%	流通股本2,524万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"DSGN","market":"US","secType":"STK","nameCN":"Design Therapeutics, Inc.","latestPrice":6.265,"timestamp":1734976597231,"preClose":6.25,"halted":0,"volume":56334,"delay":0,"floatShares":25236364,"shares":56621037,"eps":-0.846552,"marketStatus":"交易中","marketStatusCode":2,"change":0.015,"latestTime":"12-23 12:57:22 EST","open":6.09,"high":6.29,"low":6.04,"amount":346958.2893,"amplitude":0.04,"askPrice":6.3,"askSize":141,"bidPrice":6.24,"bidSize":493,"shortable":3,"etf":0,"ttmEps":-0.846552,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734987600000},"adr":0,"listingDate":1616731200000,"adjPreClose":6.25,"preHourTrading":{"tag":"盘前","latestPrice":6.17,"preClose":6.25,"latestTime":"09:29 EST","volume":1210,"amount":6763.420114,"timestamp":1734964198429},"postHourTrading":{"tag":"盘后","latestPrice":6.25,"preClose":6.25,"latestTime":"16:20 EST","volume":46230,"amount":288937.5,"timestamp":1734729600746},"volumeRatio":0.316563,"impliedVol":0.9867,"impliedVolPercentile":0.259},"requestUrl":"/m/hq/s/DSGN/wiki","defaultTab":"wiki","newsList":[{"id":"2492174784","title":"Design Therapeutics, Inc.盘中异动 大幅下跌5.04%报5.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492174784","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492174784?lang=zh_cn&edition=full","pubTime":"2024-12-19 23:02","pubTimestamp":1734620554,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日23时02分，Design Therapeutics, Inc.股票出现波动，股价大幅下跌5.04%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.49%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121923023495ea7b86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121923023495ea7b86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","LENZ","DSGN","BK4505"],"gpt_icon":0},{"id":"2491394371","title":"Design Therapeutics, Inc.盘中异动 股价大跌5.21%报5.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491394371","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491394371?lang=zh_cn&edition=full","pubTime":"2024-12-13 23:15","pubTimestamp":1734102954,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日23时15分，Design Therapeutics, Inc.股票出现异动，股价急速跳水5.21%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213231555984bd8cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213231555984bd8cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","DSGN","BK4505","BK4139","LENZ"],"gpt_icon":0},{"id":"2489149689","title":"Design Therapeutics, Inc.盘中异动 下午盘急速上涨5.01%报6.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489149689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489149689?lang=zh_cn&edition=full","pubTime":"2024-12-05 03:31","pubTimestamp":1733340661,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日03时31分，Design Therapeutics, Inc.股票出现波动，股价急速上涨5.01%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205033101ab5db65a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205033101ab5db65a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DSGN","BK4505","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2488455929","title":"Design Therapeutics, Inc.盘中异动 大幅下跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488455929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488455929?lang=zh_cn&edition=full","pubTime":"2024-12-04 01:46","pubTimestamp":1733248006,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日01时46分，Design Therapeutics, Inc.股票出现波动，股价急速跳水5.41%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.81%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204014646971b669e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204014646971b669e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","LENZ","DSGN","BK4505"],"gpt_icon":0},{"id":"2486088740","title":"Design Therapeutics, Inc.盘中异动 大幅上涨5.52%报5.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486088740","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486088740?lang=zh_cn&edition=full","pubTime":"2024-11-27 02:30","pubTimestamp":1732645834,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日02时30分，Design Therapeutics, Inc.股票出现波动，股价快速上涨5.52%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127023034a257ab68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127023034a257ab68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","LENZ","DSGN","BK4539"],"gpt_icon":0},{"id":"2484729826","title":"Design Therapeutics, Inc.盘中异动 早盘股价大跌5.69%报5.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484729826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484729826?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:13","pubTimestamp":1731942797,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时13分，Design Therapeutics, Inc.股票出现异动，股价大幅下跌5.69%。截至发稿，该股报5.47美元/股，成交量1.0545万股，换手率0.02%，振幅3.45%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118231318971a7353&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118231318971a7353&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DSGN","BK4139","BK4539","LENZ","BK4505"],"gpt_icon":0},{"id":"2483737201","title":"Design Therapeutics, Inc.盘中异动 早盘急速下跌6.61%报5.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483737201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483737201?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:32","pubTimestamp":1731681161,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时32分，Design Therapeutics, Inc.股票出现异动，股价急速跳水6.61%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.15%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522324198e42ecb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522324198e42ecb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","DSGN","BK4139","BK4539","BK4505"],"gpt_icon":0},{"id":"2483288116","title":"Design Therapeutics, Inc.盘中异动 股价大涨5.79%报7.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483288116","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483288116?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:43","pubTimestamp":1731509009,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时43分，Design Therapeutics, Inc.股票出现波动，股价快速上涨5.79%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322433098e425ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322433098e425ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","DSGN","BK4505","LENZ"],"gpt_icon":0},{"id":"2482348514","title":"Design Therapeutics Inc 预计每股亏损27美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482348514","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482348514?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:03","pubTimestamp":1731081798,"startTime":"0","endTime":"0","summary":"Design Therapeutics Inc 预计每股亏损27美分 - 财报前瞻Design Therapeutics Inc DSGN.OQ DSGN.O预计在公布截至2024年12月31日的财报时，季度收入将保持不变。LSEG 的分析师平均预计 Design Therapeutics Inc 每股亏损 27 美分。华尔街对 Design Therapeutics Inc 的 12 个月目标价中位数为 5.00 美元，低于其上次收盘价 5.79 美元。11月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4S3MF1UW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSGN","LENZ"],"gpt_icon":0},{"id":"2481884504","title":"Design Therapeutics, Inc.盘中异动 早盘快速下跌5.01%报5.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481884504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481884504?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:40","pubTimestamp":1731080451,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时40分，Design Therapeutics, Inc.股票出现异动，股价急速下挫5.01%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108234051a224eae3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108234051a224eae3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DSGN","BK4539","BK4139","BK4505","LENZ"],"gpt_icon":0},{"id":"2481981163","title":"Design Therapeutics, Inc.盘中异动 早盘急速上涨5.76%报5.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481981163","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481981163?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:14","pubTimestamp":1730906080,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日23时14分，Design Therapeutics, Inc.股票出现波动，股价快速上涨5.76%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106231440a21d43a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106231440a21d43a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4505","BK4139","LENZ","DSGN"],"gpt_icon":0},{"id":"2479346630","title":"Design Therapeutics, Inc.盘中异动 快速下跌5.56%报5.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479346630","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479346630?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:53","pubTimestamp":1730386407,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时53分，Design Therapeutics, Inc.股票出现异动，股价快速下挫5.56%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.42%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031225327ab8bf528&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031225327ab8bf528&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","DSGN","LENZ","BK4505"],"gpt_icon":0},{"id":"2479236203","title":"Design Therapeutics, Inc.盘中异动 大幅下跌5.61%报5.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479236203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479236203?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:30","pubTimestamp":1730219426,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日00时30分，Design Therapeutics, Inc.股票出现异动，股价快速下跌5.61%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103000302698e3f278&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103000302698e3f278&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DSGN","BK4505","LENZ","BK4539","BK4139"],"gpt_icon":0},{"id":"2478661781","title":"Design Therapeutics, Inc.盘中异动 下午盘急速下挫5.65%报5.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478661781","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478661781?lang=zh_cn&edition=full","pubTime":"2024-10-25 03:02","pubTimestamp":1729796529,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日03时02分，Design Therapeutics, Inc.股票出现波动，股价快速跳水5.65%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025030210971a221a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025030210971a221a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DSGN","BK4539","LENZ","BK4139","BK4505"],"gpt_icon":0},{"id":"2476435905","title":"Design Therapeutics, Inc.盘中异动 下午盘股价大涨5.49%报5.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476435905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476435905?lang=zh_cn&edition=full","pubTime":"2024-10-18 03:28","pubTimestamp":1729193323,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日03时28分，Design Therapeutics, Inc.股票出现异动，股价急速拉升5.49%。截至发稿，该股报5.96美元/股，成交量23.5572万股，换手率0.42%，振幅5.13%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018032843971a0e75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018032843971a0e75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DSGN","BK4139","BK4539","LENZ","BK4505"],"gpt_icon":0},{"id":"2474097864","title":"Design Therapeutics, Inc.盘中异动 早盘大幅拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474097864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474097864?lang=zh_cn&edition=full","pubTime":"2024-10-11 22:05","pubTimestamp":1728655537,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日22时05分，Design Therapeutics, Inc.股票出现波动，股价急速拉升5.03%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101122053798e3be3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101122053798e3be3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DSGN","BK4539","LENZ","BK4139","BK4505"],"gpt_icon":0},{"id":"2474627887","title":"Design Therapeutics, Inc.盘中异动 临近午盘大幅下跌5.08%报4.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474627887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474627887?lang=zh_cn&edition=full","pubTime":"2024-10-09 23:38","pubTimestamp":1728488297,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日23时38分，Design Therapeutics, Inc.股票出现异动，股价急速下挫5.08%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100923381798e3b806&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100923381798e3b806&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DSGN","BK4539","LENZ","BK4139","BK4505"],"gpt_icon":0},{"id":"2472614803","title":"Design Therapeutics, Inc.盘中异动 早盘大幅下跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472614803","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472614803?lang=zh_cn&edition=full","pubTime":"2024-10-03 22:28","pubTimestamp":1727965717,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日22时28分，Design Therapeutics, Inc.股票出现异动，股价急速下挫5.43%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410032228389719e345&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410032228389719e345&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","DSGN","BK4139","BK4539","BK4505"],"gpt_icon":0},{"id":"2468678681","title":"Design Therapeutics, Inc.盘中异动 股价大涨5.41%报5.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468678681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468678681?lang=zh_cn&edition=full","pubTime":"2024-09-20 02:56","pubTimestamp":1726772174,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日02时56分，Design Therapeutics, Inc.股票出现异动，股价大幅拉升5.41%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.58%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920025614ab64ab47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920025614ab64ab47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BK4505","DSGN","LENZ"],"gpt_icon":0},{"id":"2467770791","title":"Design Therapeutics, Inc.盘中异动 大幅跳水5.31%报5.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467770791","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467770791?lang=zh_cn&edition=full","pubTime":"2024-09-13 23:47","pubTimestamp":1726242464,"startTime":"0","endTime":"0","summary":"北京时间2024年09月13日23时47分，Design Therapeutics, Inc.股票出现异动，股价大幅下跌5.31%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240913234744ab63a58c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240913234744ab63a58c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","LENZ","DSGN","BK4539"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.designtx.com","stockEarnings":[{"period":"1week","weight":0.1161},{"period":"1month","weight":0.1405},{"period":"3month","weight":0.0629},{"period":"6month","weight":0.8491},{"period":"1year","weight":1.4606},{"period":"ytd","weight":1.3585}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Design Therapeutics, Inc.于2017年12月18日根据特拉华州法律成立。他们是一家临床阶段的生物制药公司，开创了新的小分子治疗候选物，称为GeneTACs，旨在用于疾病治疗。某些核苷酸重复扩增疾病，如FA，可导致特异性mRNAs表达降低；在其他疾病，如强直性肌营养不良1型(DM1)、FECD和Huntington病，核苷酸重复扩增可导致毒性基因产物的产生，通常与病理性核病灶有关。他们的基因被设计成选择性地与基因重复序列结合，通过恢复或阻断mRNA转录来调节基因表达，并恢复细胞健康。作为一个平台，他们相信GeneTACs在单基因核苷酸重复序列扩增疾病中具有广泛的潜在适用性。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.250058},{"month":2,"riseRate":0.666667,"avgChangeRate":0.04907},{"month":3,"riseRate":0.666667,"avgChangeRate":0.151963},{"month":4,"riseRate":0.25,"avgChangeRate":-0.098031},{"month":5,"riseRate":0.5,"avgChangeRate":0.01688},{"month":6,"riseRate":0.5,"avgChangeRate":-0.04322},{"month":7,"riseRate":0.75,"avgChangeRate":0.24854},{"month":8,"riseRate":0.5,"avgChangeRate":-0.178959},{"month":9,"riseRate":0.25,"avgChangeRate":-0.039002},{"month":10,"riseRate":0.25,"avgChangeRate":-0.040003},{"month":11,"riseRate":0.75,"avgChangeRate":0.071349},{"month":12,"riseRate":0.75,"avgChangeRate":0.039416}],"exchange":"NASDAQ","name":"Design Therapeutics, Inc.","nameEN":"Design Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Design Therapeutics, Inc.(DSGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Design Therapeutics, Inc.(DSGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Design Therapeutics, Inc.,DSGN,Design Therapeutics, Inc.股票,Design Therapeutics, Inc.股票老虎,Design Therapeutics, Inc.股票老虎国际,Design Therapeutics, Inc.行情,Design Therapeutics, Inc.股票行情,Design Therapeutics, Inc.股价,Design Therapeutics, Inc.股市,Design Therapeutics, Inc.股票价格,Design Therapeutics, Inc.股票交易,Design Therapeutics, Inc.股票购买,Design Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Design Therapeutics, Inc.(DSGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Design Therapeutics, Inc.(DSGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}